SEC Filing Update: #AVTX Avalo Therapeutics, Inc. : $18.85

Sector: Healthcare | YTD: 🔼+ 11.01% The SEC disclosed Today (14-AUG-2026) that T. Rowe Price Investment Management, Inc. has DECREASED #AVTX Shares by -99.83% 🔴 Deep Track Capital, LP also reported an increase in its holdings on the same day. * Previous Holdings: 2.16M Shares * Current Holdings: 3.67K Shares * Decrease -2.16M * Decreased (%)-99.83% * Ownership: 0.0% https://www.thinksabio.com/reports/isr/AVTX Institutional ownership in #AVTX has been steadily rising over the past 4 quarters in Shares: Q2 2025: 7.84M Q3 2025: 15.32M Q4 2025: 19.89M Q1 2026: 31.10M 📌 Institutional activity in the last 30 days for #AVTX: • FMR LLC – Increased holdings by 1,911,815 shares (06-AUG-2026) • STATE STREET CORP – Increased holdings by 2,817,633 shares (07-AUG-2026) • FMR LLC – Increased holdings by 637,750 shares (07-AUG-2026) • Deep Track Capital, LP – Increased holdings by 554,973 shares (14-AUG-2026) • BLACKROCK INC – Increased holdings by 3,088,649 shares (27-JUL-2026)